Artemotil Artecef.
The ethyl ether derivative of artemesinin, artemotil, has been developed by Artecef for the potential treatment of malaria. Adult and pediatric intramuscular formulations of the product were filed for approval in The Netherlands in January 1997 [236187]; registration for the two formulations followed in May 2000 [401672].